SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-176267
Filing Date
2007-08-09
Accepted
2007-08-09 06:04:43
Documents
5
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2007 d10q.htm 10-Q 224008
2 AMENDMENT NO. 2 TO CONSULTING AGREEMENT dex10103.htm EX-10.103 5428
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9576
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9651
5 SECTION 906 CEO & CFO CERTIFICATION dex32.htm EX-32 3961
  Complete submission text file 0001193125-07-176267.txt   254013
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 071037684
SIC: 2834 Pharmaceutical Preparations